| Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma N Weidner, J Folkman, F Pozza, P Bevilacqua, EN Allred, DH Moore, ... JNCI: Journal of the National Cancer Institute 84 (24), 1875-1887, 1992 | 3277 | 1992 |
| Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial C Gridelli, F Perrone, C Gallo, S Cigolari, A Rossi, F Piantedosi, ... Journal of the National Cancer Institute 95 (5), 362-372, 2003 | 1069 | 2003 |
| Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation PB Vermeulen, G Gasparini, SB Fox, M Toi, L Martin, P McCulloch, ... European Journal of Cancer 32 (14), 2474-2484, 1996 | 936 | 1996 |
| Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo … G Agnelli, G Gussoni, C Bianchini, M Verso, M Mandalà, L Cavanna, ... The lancet oncology 10 (10), 943-949, 2009 | 732 | 2009 |
| Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma G Gasparini, E Bonoldi, C Gatti, O Vinante, M Toi, T Tominaga, M Gion, ... Journal of the National Cancer Institute 89 (2), 139-147, 1997 | 696 | 1997 |
| Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. G Gasparini, AL Harris Journal of clinical oncology 13 (3), 765-782, 1995 | 690 | 1995 |
| Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours PB Vermeulen, G Gasparini, SB Fox, C Colpaert, LP Marson, M Gion, ... European journal of cancer 38 (12), 1564-1579, 2002 | 631 | 2002 |
| Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. G Gasparini, N Weidner, P Bevilacqua, S Maluta, P Dalla Palma, O Caffo, ... Journal of clinical oncology 12 (3), 454-466, 1994 | 606 | 1994 |
| Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy … P Maione, F Perrone, C Gallo, L Manzione, FV Piantedosi, S Barbera, ... Journal of Clinical Oncology 23, 6865-6872, 2005 | 564 | 2005 |
| Prognostic value of vascular endothelial growth factor in breast cancer G Gasparini The oncologist 5 (S1), 37-44, 2000 | 482 | 2000 |
| Angiogenesis: pathological, prognostic, and growth-factor pathways and their link to trial design and anticancer drugs SB Fox, G Gasparini, AL Harris The lancet oncology 2 (5), 278-289, 2001 | 438 | 2001 |
| Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis. F Pezzella, U Pastorino, E Tagliabue, S Andreola, G Sozzi, G Gasparini, ... The American journal of pathology 151 (5), 1417, 1997 | 433 | 1997 |
| Intratumoral microvessel density and L53 protein: Correlation with metastasis in head‐and‐neck squamous‐cell carcinoma G Gasparini, N Weidner, S Maluta, F Pozza, P Boracchi, M Mezzetti, ... International journal of cancer 55 (5), 739-744, 1993 | 432 | 1993 |
| Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents? G Gasparini, R Longo, R Sarmiento, A Morabito The lancet oncology 4 (10), 605-615, 2003 | 430 | 2003 |
| Vascular integrin alpha (v) beta3: a new prognostic indicator in breast cancer. G Gasparini, PC Brooks, E Biganzoli, PB Vermeulen, E Bonoldi, LY Dirix, ... Clinical cancer research: an official journal of the American Association …, 1998 | 427 | 1998 |
| A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score M Verso, G Agnelli, S Barni, G Gasparini, R LaBianca Internal and emergency medicine 7, 291-292, 2012 | 391 | 2012 |
| Metronomic scheduling: the future of chemotherapy? G Gasparini The lancet oncology 2 (12), 733-740, 2001 | 342 | 2001 |
| Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non–small-cell lung cancer: A phase III trial of the Italian … C Gridelli, C Gallo, FA Shepherd, A Illiano, F Piantedosi, SF Robbiati, ... Journal of Clinical Oncology 21 (16), 3025-3034, 2003 | 341 | 2003 |
| Evaluating the potential usefulness of new prognostic and predictive indicators on node-negative breast cancer patients G Gasparini, F Pozza, AL Harris JNCI: Journal of the National Cancer Institute 85 (15), 1206-1219, 1993 | 313 | 1993 |
| Expression of vascular endothelial growth factor can predict event-free survival in stage II colon cancer S Cascinu, MP Staccioli, G Gasparini, P Giordani, V Catalano, R Ghiselli, ... Clinical Cancer Research 6 (7), 2803-2807, 2000 | 302 | 2000 |
